One #coronavirus question I get asked a lot: How dangerous is it? @CNN -- 1/20
You may have heard that the case fatality rate (CFR) is around 2%. This is the proportion of infections that result in death. That is: the number of deaths/the total number of infected. #coronavirus -- 2/20
A Chinese study of tens of thousands of #coronavirus cases found a CFR of 2.3%. That’s the headline, but let’s take a deeper look at what the data reveals. bit.ly/2IeNPfm -- 3/20
For example, CFRs are higher for some groups vs. others. In fact, we can break it down by age, health conditions and gender. For example, people in their 80s had a CFR closer to 15%, whereas those in their 30s had a CFR closer to 0.2%. #coronavirus -- 4/20
Roughly 8 in 10 deaths in that study were 60 or older. Because that is a population most at risk, we must do more to protect them. #coronavirus -- 5/20
Same goes with certain pre-existing conditions. According to the study, heart disease was the most prominent risk factor in terms of CFR, followed by diabetes, lung disease and hypertension. #coronavirus -- 6/20
And, there is even a difference when it comes to gender. Men are more likely to die compared to women. #coronavirus -- 7/20
On the other hand, children don't seem to be affected as much. In the Chinese study, there were no deaths under 10 years old, and only one under 20. #coronavirus -- 8/20
Overall, more than 80% of cases had mild disease. Around 14% had severe disease. Nearly 5% had critical disease and were at increased risk of dying. bit.ly/2wn3Wox#coronavirus -- 9/20
It’s also worth a deeper dive into the geography. In Hubei Province, where the outbreak started, CFR was seven times higher than the rest of China: 2.9% vs. 0.4%. Why? #coronavirus -- 10/20
Well, this may reflect “severe” pressure on the health care system there, @DrMikeRyan of @WHO said last month. #coronavirus -- 11/20
But China "has got much better at prioritizing those more likely be severely ill," Ryan added. Those are important lessons that will hopefully be applied elsewhere in the world. #coronavirus -- 12/20
When it comes to the rest of the world, because the numbers are smaller, it is harder to draw significant findings from them. #coronavirus -- 13/20
But according to @WHO’s latest numbers, the severity of the virus may be less outside of China, with 104 deaths among 7,169 confirmed cases in other countries. That is a CFR closer to 1.5% bit.ly/32IO37T#coronavirus -- 14/20
Next may be the most important point. Because so many people (~80%) exposed to coronavirus have minimal symptoms, they are harder to count. #coronavirus -- 15/20
Think about it. Most people with mild symptoms never go to the hospital and therefore don’t get tested, and more importantly don’t get counted. #coronavirus -- 16/20
Remember the case fatality rate (CFR) is the number of deaths/the total number of people infected. So, if the number of deaths stays the same but the number of infections goes up, then the overall CFR goes down. #coronavirus -- 17/20
So, for example, if there were really twice as many infections as had been officially counted, then the CFR would be closer to 1% instead of 2%. “The denominator of the equation is likely much much larger," according to @NIAIDNews Director Dr. Anthony Fauci. #coronavirus -- 18/20
As we start increased testing this week, we'll likely find many more cases of coronavirus here in the US and abroad, including mild illnesses who might have otherwise gone under the radar. #coronavirus -- 19/20
While that may dramatically increase the number of cases, it may also significantly lower the case fatality ratio (CFR), and that may be some welcome news. #coronavirus -- 20/20
• • •
Missing some Tweet in this thread? You can try to
force a refresh
As of today, we have two newly authorized treatments for early Covid-19 in high-risk patients — @pfizer 's Paxlovid and @Merck 's molnupiravir. (1/ cnn.com/2021/12/22/hea…
Paxlovid is for ages 12+ at high risk of severe disease. It was found to lower the risk of hospitalization or death by about 88%. (2/
For molnupiravir, that number is around 30%. It is for ages 18+ who are at high risk, not recommended if you’re pregnant, and for when alternatives aren’t available or appropriate. (3/
@CDC’s new guidance recommends #vaccinated people in areas of high or substantial transmission to mask when in indoor public spaces. Why? As the @CDCgov director explained new data finds vaccinated people with #Deltavariant can carry the same viral load as those not 💉 (1/7)
Back on May 13, when @CDCgov first changed their guidance, #DeltaVariant made up about 1.4% of all reported cases. Now it makes up 83% of cases (2/7).
This raises questions about how easily #vaccinated people can transmit #Covid_19. It Is important to point out there is little correlation between viral load and symptoms. One can have a high viral load, but few symptoms. The vaccines are still doing their job (3/7).
While we are beginning to feel the light on our faces after this pandemic, part of me wonders if we will actually take away the lessons we learned this past year. We owe it to every life lost to make sure this never happens again. I hope you’ll be watching tonight. #CovidWar
Dr. Fauci told me that this virus is evil...but also extraordinary. Where could something so dangerous really come from, and how was it so perfectly adapted to spread in human populations? Keep watching to find out. #CovidWar
Dr. Fauci also told me “this is a war. So if you're going to fight a war, you better start shooting at the enemy instead of at each other.” How exactly did politics impact our response to Covid-19? #CovidWar
Having 3 authorized vaccines is an incredible scientific feat, but like I’ve said before: vaccines aren’t vaccinations. So, still have lingering vaccine questions?@CarlosdelRio7@PreetiNMalani did the work for you and broke down what we know. 1/8
When it comes to which vaccine you should receive, they say get whatever is available. Eventually, when there's more supply, the mrRNA vaccines could provide an advantage for higher risk folks. J&J vaccine is great for people who wouldn’t be able to return for a 2nd dose. 2/8
There isn’t clear evidence that the vaccines prevent transmission yet. There’s some early data that this could be the case, but they add that: “Protection against transmission may be difficult to prove because a decline in infections may be due to multiple factors.” 3/8
It’s important to remember that coronaviruses mutate all the time. And, the more they spread, the more mutations can happen. That is why simply reducing transmission is the key to reducing new variants. (1/8)
So far we have identified variants by calling them things like B.1.1.7 or B.1.351, or associating them with where they were first identified. (2/8)
But, a group of researchers has found a better way - naming them after birds - or at least that’s what they did for a new crop of variants that they’ve found in the US. (I personally love the bird names -- naming variants like we name hurricanes) (⅜) cnn.com/2021/02/14/hea…
I know you may have concerns about the new variants and whether our current vaccines will work against them. Some good news: a new lab study shows @pfizer 's vaccine offers solid protection against the variant first seen in South Africa aka B.1.351. (1/7)
Researchers tested an engineered version of the variant (B.1.351) against blood samples from people who had received two doses of the Pfizer-BioNTech vaccine (2/7)
There was a reduction in neutralizing antibody activity against the variant, but researchers said it was still enough to neutralize the virus. (3/7) cnn.com/2021/02/17/hea…